UY31995A - Uso de idrabiotaparinux para disminuir la incidencia de hemorragias durante un tratamiento antitrombótico - Google Patents
Uso de idrabiotaparinux para disminuir la incidencia de hemorragias durante un tratamiento antitrombóticoInfo
- Publication number
- UY31995A UY31995A UY0001031995A UY31995A UY31995A UY 31995 A UY31995 A UY 31995A UY 0001031995 A UY0001031995 A UY 0001031995A UY 31995 A UY31995 A UY 31995A UY 31995 A UY31995 A UY 31995A
- Authority
- UY
- Uruguay
- Prior art keywords
- idrabiotaparinux
- treatment
- incidence
- decrease
- during
- Prior art date
Links
- MUQWDYYIYNYBQD-OFHININYSA-N (2s,3s,4s,5r,6r)-3-[(2r,3r,4r,5s,6r)-3-[6-[5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexanoylamino]-4,5-dimethoxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-6-[(2r,3s,4s,5r,6r)-2-carboxy-4,5-dimethoxy- Chemical compound OS(=O)(=O)O[C@@H]1[C@@H](OS(O)(=O)=O)[C@@H](OC)O[C@H](COS(O)(=O)=O)[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@H](O[C@H]3[C@@H]([C@@H](OC)[C@H](O[C@@H]4[C@@H]([C@@H](OC)[C@H](OC)[C@@H](COS(O)(=O)=O)O4)NC(=O)CCCCCNC(=O)CCCC[C@H]4[C@H]5NC(=O)N[C@H]5CS4)[C@H](O3)C(O)=O)OC)[C@@H](COS(O)(=O)=O)O2)OS(O)(=O)=O)[C@H](C(O)=O)O1 MUQWDYYIYNYBQD-OFHININYSA-N 0.000 title abstract 3
- 208000032843 Hemorrhage Diseases 0.000 abstract 2
- 230000007170 pathology Effects 0.000 abstract 1
- 230000009863 secondary prevention Effects 0.000 abstract 1
- 230000001732 thrombotic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Abstract
La invención se refiere al uso de idrabiotaparinux para el tratamiento y la prevención secundaria de patologías trombóticas, en el que el uso de idrabiotaparinux implica una disminución en la incidencia de hemorragias, en particular hemorragias masivas, durante dicho tratamiento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08290704A EP2145624A1 (en) | 2008-07-18 | 2008-07-18 | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| EP09290216A EP2233143A1 (en) | 2009-03-24 | 2009-03-24 | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY31995A true UY31995A (es) | 2010-02-26 |
Family
ID=41203891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001031995A UY31995A (es) | 2008-07-18 | 2009-07-17 | Uso de idrabiotaparinux para disminuir la incidencia de hemorragias durante un tratamiento antitrombótico |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20110245200A1 (es) |
| EP (1) | EP2315593A1 (es) |
| JP (1) | JP2011528345A (es) |
| KR (1) | KR20110044747A (es) |
| CN (1) | CN102149389A (es) |
| AR (1) | AR072520A1 (es) |
| AU (1) | AU2009272373A1 (es) |
| BR (1) | BRPI0915947A2 (es) |
| CA (1) | CA2730975A1 (es) |
| IL (1) | IL210692A0 (es) |
| MX (1) | MX2011000673A (es) |
| RU (1) | RU2011106037A (es) |
| TW (1) | TW201006479A (es) |
| UY (1) | UY31995A (es) |
| WO (1) | WO2010007530A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2721044B1 (en) * | 2011-06-17 | 2015-11-18 | Carbomimetics | Synthetic pentasaccharides having short half-life and high activity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2814463B1 (fr) * | 2000-09-22 | 2002-11-15 | Sanofi Synthelabo | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
| FR2874924B1 (fr) * | 2004-09-09 | 2006-12-01 | Sanofi Aventis Sa | Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique |
| MY145269A (en) * | 2005-10-10 | 2012-01-13 | Organon Nv | Antithrombotic dual inhibitors comprising a biotin label |
-
2009
- 2009-07-16 TW TW098124139A patent/TW201006479A/zh unknown
- 2009-07-17 BR BRPI0915947-9A patent/BRPI0915947A2/pt not_active IP Right Cessation
- 2009-07-17 RU RU2011106037/15A patent/RU2011106037A/ru unknown
- 2009-07-17 MX MX2011000673A patent/MX2011000673A/es not_active Application Discontinuation
- 2009-07-17 KR KR1020117001141A patent/KR20110044747A/ko not_active Withdrawn
- 2009-07-17 JP JP2011518028A patent/JP2011528345A/ja active Pending
- 2009-07-17 US US13/003,623 patent/US20110245200A1/en not_active Abandoned
- 2009-07-17 AR ARP090102729A patent/AR072520A1/es not_active Application Discontinuation
- 2009-07-17 CA CA2730975A patent/CA2730975A1/en not_active Abandoned
- 2009-07-17 CN CN2009801352734A patent/CN102149389A/zh active Pending
- 2009-07-17 EP EP09786171A patent/EP2315593A1/en not_active Withdrawn
- 2009-07-17 UY UY0001031995A patent/UY31995A/es not_active Application Discontinuation
- 2009-07-17 WO PCT/IB2009/006621 patent/WO2010007530A1/en not_active Ceased
- 2009-07-17 AU AU2009272373A patent/AU2009272373A1/en not_active Abandoned
-
2011
- 2011-01-16 IL IL210692A patent/IL210692A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009272373A1 (en) | 2010-01-21 |
| RU2011106037A (ru) | 2012-08-27 |
| JP2011528345A (ja) | 2011-11-17 |
| MX2011000673A (es) | 2011-04-04 |
| IL210692A0 (en) | 2011-03-31 |
| TW201006479A (en) | 2010-02-16 |
| WO2010007530A1 (en) | 2010-01-21 |
| AR072520A1 (es) | 2010-09-01 |
| EP2315593A1 (en) | 2011-05-04 |
| US20110245200A1 (en) | 2011-10-06 |
| KR20110044747A (ko) | 2011-04-29 |
| CN102149389A (zh) | 2011-08-10 |
| BRPI0915947A2 (pt) | 2019-04-09 |
| CA2730975A1 (en) | 2010-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017500930A1 (en) | Hsp90 inhibitor combinations | |
| TW201129938A (en) | Personal mapping system | |
| MX338884B (es) | Composiciones y metodos que comprenden variantes de proteasa. | |
| CL2009001263S1 (es) | Maquina de afeitar. | |
| IN2012DN01869A (es) | ||
| ECSP11011417A (es) | Anticuerpos anti-fgfr3 y métodos que los utilizan | |
| MX349787B (es) | Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido. | |
| EA201171367A1 (ru) | Винилиндазолильные соединения | |
| ECSP13012394A (es) | Nuevas formas de dosificación de liberación modificada de un inhibidor de la xantina oxidorreductasa o de inhibidores de xantina oxidasa | |
| CL2011001811A1 (es) | Un metodo para tratar un paciente que ha sufrido un infarto agudo al miocardio que comprende el uso de un agente antifibrotico. | |
| PH12013500065A1 (en) | Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof | |
| BR112012001706A2 (pt) | composição de limpeza tendo autoadesão elevada e que fornece benefícios residuais. | |
| BR112012000777A2 (pt) | embalagem de bateria. | |
| CL2009001363S1 (es) | Pieza para maquina de afeitar. | |
| UA104469C2 (uk) | Спосіб запобігання діареї мандрівників | |
| MX2010003591A (es) | Capa protectora mecanica para formas de dosificacion solidas. | |
| CR11755A (es) | Dronedarona para la prevencion de la cardioversion | |
| IT1395957B1 (it) | Uso di una combinazione di d-aspartato e l-aspartato per il trattamento della infertilita' maschile. | |
| JP2012513655A5 (es) | ||
| UY31995A (es) | Uso de idrabiotaparinux para disminuir la incidencia de hemorragias durante un tratamiento antitrombótico | |
| CL2012001761A1 (es) | Método para la reducción y/o control de incrustaciones en un sistema, que comprende la adición de una composición de trimetilglicina en el sistema de reducción y acumulación de incrustaciones. | |
| CR11628A (es) | ASOCIACION DE UN INHIBIDOR DE CORRIENTE SINUSUAL If Y DE UN BETA-BLOQUEANTE | |
| MY154024A (en) | Oral care compositions and methods | |
| PA8849101A1 (es) | Procedimiento de preparación del hemifumarato de eplivanserina | |
| UA41922U (ru) | Применение альтана как вещества с противолучевыми свойствами |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20140410 |